Medical Crossfire®:The Contemporary Management of Hypoparathyroidism


This educational activity is supported by an independent medical educational grant from Shire.
 
 
This activity is jointly provided by Global Education Group and Physicians’ Education Resource®, LLC.

On Demand Medical Crossfire® Activity

Faculty

Chair/Moderator
Stephen Brunton, MD
Executive Director
Primary Care Metabolic Group
Los Angeles, California
 
Peter Angelos, MD, PhD, FACS
Linda Kohler Anderson Professor of Surgery and Surgery Ethics
Chief, Endocrine Surgery
Associate Director, MacLean Center for Clinical Medical Ethics
The University of Chicago
Chicago, Illinois
 
Ji (CJ) Chun, PA-C, MPAS
Physician Assistant, OptumCare Medical Group: Endocrinology
Orange County, California
President, American Society of Endocrine Physician Assistants
Adjunct Faculty, A.T. Still University/Arizona School of Health & Sciences
Mesa, Arizona
 
Aliya Khan, MD, FRCPC, FACP, FACE
Professor of Clinical Medicine, Division of Endocrinology and Metabolism
Director of Calcium Disorders Clinic
Director, Fellowship in Metabolic Bone Disease
McMaster University
Hamilton, Ontario

Activity Overview

During this Medical Crossfire, expert faculty in the field of endocrinology will engage in a roundtable discussion that includes an endocrinologist, an endocrine surgeon, a physician assistant, and a primary care professional to discuss the most recent developments in the diagnosis and management of hypoparathyroidism. Unlike primary hyperparathyroidism, which is relatively common, hypoparathyroidism has not received the same level of attention and discussion until recently, as new guidelines have been developed to help clinicians diagnose, evaluate, and manage this disorder. Concomitantly, the recent approval of recombinant human PTH replacement therapy is expected to result in dramatic changes to the treatment landscape for this condition. This panel discussion includes experience-based strategies for improving diagnosis, highlights of the new treatment guidelines, and both conventional and novel treatment pathways. The program concludes with case studies to demonstrate the application of the new evidence-based guidelines.

Educational Objectives

At the completion of this activity, the participant will be able to:
  • ARTICULATE the burden, clinical presentation, and diagnostic features of hypoparathyroidism
  • DETERMINE the benefits and challenges of conventional treatment with calcium and vitamin D
  • EXPLAIN the efficacy, safety, and role of parathyroid hormone replacement therapy in the management of hypoparathyroidism
  • INTEGRATE new guidelines on the diagnosis and management of hypoparathyroidism
 
Targeted Audience: Endocrinologists, surgeons, internists, and other healthcare professionals with interest in hypoparathyroidism
Length of Medical Crossfire: 1 hour
Release Date: November 30, 2017
Expiration Date: November 30, 2018
Fee: Free






Become a Member

Forgot Password?
Filter By